CD4 and neoplasm: The differences in observed results between the flow cytometry and immunostaining for CD4+ and CD8+ cells in both tumors are presumably due to the separate cohorts of mice used for analysis along with the types of fluorescent markers and the numbers of cells counted from a larger volume versus region of interests on 4–6 sections of each tumor type.